Influenza A virus H1N1 vaccine inactivated - Serum Institute of India

Drug Profile

Influenza A virus H1N1 vaccine inactivated - Serum Institute of India

Alternative Names: Enzavac; H1N1 influenza vaccine inactivated - Serum Institute of India; Influenza vaccine (whole virion, inactivated) A/H1N1 (pandemic) - Serum Institute of India

Latest Information Update: 18 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Serum Institute of India
  • Class Influenza A virus H1N1 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza A virus H1N1 subtype

Most Recent Events

  • 10 Jul 2010 The Serum Institute of India completes a phase I trial in Influenza-A virus H1N1 subtype (prevention, in volunteers) in India (IM) (CTRI/2010/091/000082)
  • 01 Jun 2010 Serum Institute of India completes a phase II/III trial in Influenza-A virus H1N1 subtype in India (IM) (CTRI/2010/091/000093)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top